HHealth Read More Semaglutide Falls Short in Alzheimer’s Phase 3 TrialsMarch 21, 2026 Phase 3 trials show oral semaglutide failed to slow early Alzheimer’s progression, potentially limiting its expansion beyond metabolic…
NNutrition Read More SuppCo launches certification to verify actives in dietary supplementsMarch 3, 2026 The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
NNutrition Read More Why clinical trials on nutritional supplements are hard to designFebruary 27, 2026 Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising everything…
HHealthcare Read More Klothea initiates longevity-focused human trial of klotho therapyFebruary 25, 2026 Recruitment for Phase 1 trial of mRNA therapy begins in ‘special economic zone’ on the Caribbean island of…
MMedication Read More Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)February 21, 2026 Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…
MMedication Read More Fact Check Team: GLP-1 users getting rare pirate diseaseFebruary 21, 2026 WASHINGTON (TNND) — Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from…
MMental health Read More Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals – Endpoints NewsFebruary 17, 2026 Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals Endpoints NewsCompass Pathways Successfully Achieves Primary…
MMedication Read More Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPPFebruary 14, 2026 Disc Medicine Inc FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and…
HHealth Read More Spanish scientist finds cure for pancreatic cancer in major medical breakthrough |January 29, 2026 A Spanish research team says it has developed a treatment that completely eliminated the most aggressive form of…
MMedication Read More FDA rejects Vanda’s jet lag drug following yearslong dispute and 'long-shot' review – Endpoints NewsJanuary 12, 2026 FDA rejects Vanda’s jet lag drug following yearslong dispute and ‘long-shot’ review Endpoints NewsFDA rejects Vanda’s jet lag treatment…
MMental health Read More Short bursts of oxygen deprivation could help treat depression: Chinese studyDecember 3, 2025 Brief, controlled bouts of oxygen deprivation – essentially moments of safe suffocation – can alleviate severe depression as…
HHealth Read More There are more than 100 autoimmune diseases, and they mostly strike women. Here’s what to knowNovember 6, 2025 Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But…